Retailers race into GLP-1 market as Amazon and Walmart expand weight management programs, reshaping access and care delivery in obesity treatment.

SEATTLE, Washington — Amazon is expanding deeper into healthcare with a new national weight management program that combines primary care, pharmacy services and virtual visits aimed at patients using popular GLP-1 medications for obesity treatment.

Eli Lilly and Novo Nordisk are fighting to capture the weight-loss drug market. Amazon could complicate things.

The GLP-1 weight-loss category exploded into a multi-billion-dollar opportunity that blends medication access with ongoing patient support. This morning, Amazon‘s (NASDAQ:AMZN | AMZN Price Prediction) One Medical platform rolled out a national program that pairs GLP-1 prescriptions with primary care integration — regular check-ins,

Amazon said its GLP-1 medications are available for fast delivery across all 50 states, with same-day delivery currently offered in nearly 3,000 cities and towns. ・Amazon will offer GLP-1 drugs with insurance plans starting at $25 per month and cash-pay options from $149 per month.